UNITED THERAPEUTICS CORP DEL's ticker is and the CUSIP is 91307C952. A total of 2 filers reported holding UNITED THERAPEUTICS CORP DEL in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $13,181,000 | +8.3% | 1,016 | +13.0% | 0.86% | +31.4% |
| Q1 2017 | $12,171,000 | -22.9% | 899 | -18.3% | 0.66% | -28.5% |
| Q4 2016 | $15,777,000 | +21.7% | 1,100 | +0.2% | 0.92% | +88.9% |
| Q3 2016 | $12,965,000 | +3.5% | 1,098 | +37.2% | 0.49% | -29.5% |
| Q4 2015 | $12,529,000 | +1089.8% | 800 | +572.3% | 0.69% | +1431.1% |
| Q2 2014 | $1,053,000 | -48.4% | 119 | -45.2% | 0.04% | -60.5% |
| Q1 2014 | $2,040,000 | – | 217 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sofinnova Investments, Inc. | 94,500 | $17,443,000 | 1.03% |
| SIMPLEX TRADING, LLC | 2,900 | $535,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 1,300 | $240,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |